TrialLeukemia2017
Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial.
N J Bahlis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled ittrialcites it